Cargando…

Medulloblastoma in childhood-King Edward Memorial hospital surgical experience and review: Comparative analysis of the case series of 365 patients

AIM: Medulloblastoma is one of the most common posterior fossa tumors in childhood. The treatment-related side effects as well as predictive outcome still remain as a major challenge. The improved understanding of the disease and advances in molecular biology is changing the treatment paradigms from...

Descripción completa

Detalles Bibliográficos
Autores principales: Muzumdar, Dattatraya, Deshpande, Amit, Kumar, Ratnesh, Sharma, Ankur, Goel, Naina, Dange, Nitin, Shah, Abhida, Goel, Atul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208927/
https://www.ncbi.nlm.nih.gov/pubmed/22069434
http://dx.doi.org/10.4103/1817-1745.85717
_version_ 1782215656202043392
author Muzumdar, Dattatraya
Deshpande, Amit
Kumar, Ratnesh
Sharma, Ankur
Goel, Naina
Dange, Nitin
Shah, Abhida
Goel, Atul
author_facet Muzumdar, Dattatraya
Deshpande, Amit
Kumar, Ratnesh
Sharma, Ankur
Goel, Naina
Dange, Nitin
Shah, Abhida
Goel, Atul
author_sort Muzumdar, Dattatraya
collection PubMed
description AIM: Medulloblastoma is one of the most common posterior fossa tumors in childhood. The treatment-related side effects as well as predictive outcome still remain as a major challenge. The improved understanding of the disease and advances in molecular biology is changing the treatment paradigms from Chang's staging system to molecular risk stratification. However, surgery still remains as an important mainstay of therapy and is formidable. The role of radical surgery has always been a crucial factor in the outcome of these patients, the best survival being reported in patients who had total excision of the tumor and with no metastasis. PATIENT AND METHODS: An analysis of 365 patients (age<18 years) of medulloblastoma who underwent treatment at the Seth G.S. Medical College and King Edward VII Memorial hospital (KEM), Mumbai over a 25- year period (1985-2000 and 2001-2010) is presented. The clinical profile, radiological features, pathology and surgical nuances are discussed. RESULTS: The most common age group affected was between 3 and 12 years. 75.3% presented with headaches, vomiting and 63.2% with papilledema. Sitting position was used in majority of cases. A total of 8 patients underwent shunting; all of them were in the postoperative period (5.19%). 92.2% (142 cases) had classical medulloblastoma, 5.1% (8 cases) had desmoplastic variant, 1.9% (3 cases) had anaplastic changes and 0.6% (1 case) had glial differentiation. The 5-year and 10-year progression free survival rate was 73 and 41% for average risk disease while for high risk disease rate it was 34%. The mortality rate was 2%. The quality of life was enhanced in patients who survived 5-10 years after treatment. CONCLUSION: Surgery for medulloblastoma is formidable. The option of sitting position for medulloblastoma surgery is still viable. A vigilant neuroanesthesiologist and a safe surgery are necessary to achieve a good postoperative result. Radiological characteristics are helpful adjuncts for determining effective surgical strategy. Permanent CSF drainage can be avoided in majority of patients and can be definitively considered in progressive symptomatic hydrocephalus. A safe maximal resection and a good Karnofsky score are paramount to ensure compliance with adjuvant therapy and contribute to an overall survival advantage.
format Online
Article
Text
id pubmed-3208927
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-32089272011-11-08 Medulloblastoma in childhood-King Edward Memorial hospital surgical experience and review: Comparative analysis of the case series of 365 patients Muzumdar, Dattatraya Deshpande, Amit Kumar, Ratnesh Sharma, Ankur Goel, Naina Dange, Nitin Shah, Abhida Goel, Atul J Pediatr Neurosci Original Article AIM: Medulloblastoma is one of the most common posterior fossa tumors in childhood. The treatment-related side effects as well as predictive outcome still remain as a major challenge. The improved understanding of the disease and advances in molecular biology is changing the treatment paradigms from Chang's staging system to molecular risk stratification. However, surgery still remains as an important mainstay of therapy and is formidable. The role of radical surgery has always been a crucial factor in the outcome of these patients, the best survival being reported in patients who had total excision of the tumor and with no metastasis. PATIENT AND METHODS: An analysis of 365 patients (age<18 years) of medulloblastoma who underwent treatment at the Seth G.S. Medical College and King Edward VII Memorial hospital (KEM), Mumbai over a 25- year period (1985-2000 and 2001-2010) is presented. The clinical profile, radiological features, pathology and surgical nuances are discussed. RESULTS: The most common age group affected was between 3 and 12 years. 75.3% presented with headaches, vomiting and 63.2% with papilledema. Sitting position was used in majority of cases. A total of 8 patients underwent shunting; all of them were in the postoperative period (5.19%). 92.2% (142 cases) had classical medulloblastoma, 5.1% (8 cases) had desmoplastic variant, 1.9% (3 cases) had anaplastic changes and 0.6% (1 case) had glial differentiation. The 5-year and 10-year progression free survival rate was 73 and 41% for average risk disease while for high risk disease rate it was 34%. The mortality rate was 2%. The quality of life was enhanced in patients who survived 5-10 years after treatment. CONCLUSION: Surgery for medulloblastoma is formidable. The option of sitting position for medulloblastoma surgery is still viable. A vigilant neuroanesthesiologist and a safe surgery are necessary to achieve a good postoperative result. Radiological characteristics are helpful adjuncts for determining effective surgical strategy. Permanent CSF drainage can be avoided in majority of patients and can be definitively considered in progressive symptomatic hydrocephalus. A safe maximal resection and a good Karnofsky score are paramount to ensure compliance with adjuvant therapy and contribute to an overall survival advantage. Medknow Publications 2011-10 /pmc/articles/PMC3208927/ /pubmed/22069434 http://dx.doi.org/10.4103/1817-1745.85717 Text en Copyright: © Journal of Pediatric Neurosciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Muzumdar, Dattatraya
Deshpande, Amit
Kumar, Ratnesh
Sharma, Ankur
Goel, Naina
Dange, Nitin
Shah, Abhida
Goel, Atul
Medulloblastoma in childhood-King Edward Memorial hospital surgical experience and review: Comparative analysis of the case series of 365 patients
title Medulloblastoma in childhood-King Edward Memorial hospital surgical experience and review: Comparative analysis of the case series of 365 patients
title_full Medulloblastoma in childhood-King Edward Memorial hospital surgical experience and review: Comparative analysis of the case series of 365 patients
title_fullStr Medulloblastoma in childhood-King Edward Memorial hospital surgical experience and review: Comparative analysis of the case series of 365 patients
title_full_unstemmed Medulloblastoma in childhood-King Edward Memorial hospital surgical experience and review: Comparative analysis of the case series of 365 patients
title_short Medulloblastoma in childhood-King Edward Memorial hospital surgical experience and review: Comparative analysis of the case series of 365 patients
title_sort medulloblastoma in childhood-king edward memorial hospital surgical experience and review: comparative analysis of the case series of 365 patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208927/
https://www.ncbi.nlm.nih.gov/pubmed/22069434
http://dx.doi.org/10.4103/1817-1745.85717
work_keys_str_mv AT muzumdardattatraya medulloblastomainchildhoodkingedwardmemorialhospitalsurgicalexperienceandreviewcomparativeanalysisofthecaseseriesof365patients
AT deshpandeamit medulloblastomainchildhoodkingedwardmemorialhospitalsurgicalexperienceandreviewcomparativeanalysisofthecaseseriesof365patients
AT kumarratnesh medulloblastomainchildhoodkingedwardmemorialhospitalsurgicalexperienceandreviewcomparativeanalysisofthecaseseriesof365patients
AT sharmaankur medulloblastomainchildhoodkingedwardmemorialhospitalsurgicalexperienceandreviewcomparativeanalysisofthecaseseriesof365patients
AT goelnaina medulloblastomainchildhoodkingedwardmemorialhospitalsurgicalexperienceandreviewcomparativeanalysisofthecaseseriesof365patients
AT dangenitin medulloblastomainchildhoodkingedwardmemorialhospitalsurgicalexperienceandreviewcomparativeanalysisofthecaseseriesof365patients
AT shahabhida medulloblastomainchildhoodkingedwardmemorialhospitalsurgicalexperienceandreviewcomparativeanalysisofthecaseseriesof365patients
AT goelatul medulloblastomainchildhoodkingedwardmemorialhospitalsurgicalexperienceandreviewcomparativeanalysisofthecaseseriesof365patients